Appropriate anticoagulation for hemodialysis (HD) requires a subtle balance between under‐
and over‐heparinization to prevent extracorporeal circuit (ECC) clotting and bleeding …

End-stage renal disease (ESRD) patients on chronic hemodialysis have repeated blood
exposure to artificial surfaces that can trigger clot formation within the hemodialysis circuit …

Objectives: To address the issues of Prevention and Management of Acute Renal Failure in
the ICU Patient, using the format of an International Consensus Conference. Methods and …

In the absence of robust evidence to guide clinical decision-making, the optimal approach to
prevent stroke and systemic embolism in haemodialysis (HD) patients with atrial fibrillation …

The focus of this study is to enhance the protein fouling resistance, hydrophilicity,
biocompatibility, hemocompatibility and ability of the membranes and to reduce health …

Heparin is used to prevent clotting during hemodialysis, but heparin-free hemodialysis is
sometimes needed to decrease the risk of bleeding. The HepZero study is a randomized …

Atrial fibrillation (AF) is an important comorbidity in patients with end-stage renal disease
(ESRD) undergoing dialysis that portends increased health care utilization, morbidity, and …

The polysulfone-based membrane has been used in hemodialysis (HD) and it is
continuously developed to maintain its sustainability on the subject of biocompatibility …

It has been common practice for dialysis patients with problematic vascular access to
receive warfarin for the purposes of keeping the access functional. This, of course, increases …

Background Anticoagulation for chronic dialysis patients with contraindications to heparin
administration is challenging. Current guidelines state that in patients with increased …